NCT03564483 Gynecologic Extramammary Paget's Disease
| NCT ID | NCT03564483 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Extramammary Paget's Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2018-02-19 |
| Primary Completion | 2050-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2018-02-19 with a primary completion date of 2050-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.
Eligibility Criteria
Inclusion Criteria: * Females * Age 18 years or older * Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body * Willing and able to provide signed informed consent Exclusion Criteria: * Males * Diagnosis of Paget's Disease in body areas other than vulvar or perianal region
Contact & Investigator
Jamie N. Bakkum-Gamez, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03564483 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Extramammary Paget's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03564483 currently recruiting?
Yes, NCT03564483 is actively recruiting participants. Contact the research team at lemens.maureen@mayo.edu for enrollment information.
Where is the NCT03564483 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03564483 clinical trial?
NCT03564483 is sponsored by Mayo Clinic. The principal investigator is Jamie N. Bakkum-Gamez, M.D. at Mayo Clinic. The trial plans to enroll 100 participants.